Glucosamine medication

PheWeb

RX_GLUCOSAMINE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC M01AX05

34051

Check pre-conditions, main-only, mode, ICD version None

15880

Check minimum number of events

Min. number of events 3

15880

Include endpoints None

15880

RX_GLUCOSAMINE

Extra metadata

First used in FinnGen datafreeze DF5

Similar endpoints

↥

List of similar endpoints to Glucosamine medication based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	15473	10953	4520
Unadjusted prevalence (%)	5.01	6.31	3.35
Mean age at first event (years)	60.55	60.15	61.51

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	1.10 [0.94, 1.28]	2.3e-1	1319
15 years	0.01	0.97 [0.83, 1.13]	6.7e-1	1057
5 years	0.00	1.01 [0.85, 1.20]	9.2e-1	247
1 year	0.00	0.35 [0.21, 0.59]	8.8e-5	15

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_GLUCOSAMINE – Glucosamine medication
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Glucosamine medication
after Glucosamine medication

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Glucosamine medication

↥